Dmytro Kornyeyev

机构：Gilead Sciences (United States) · ORCID：0000-0002-2330-6729

发表论文 54 篇 · 总被引 2291 次 · h-index 22

代表论文

• Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment (2016 · Nature Communications · 被引 275)
• Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation (2020 · Journal of Hepatology · 被引 229)
• Off-Target In Vitro Profiling Demonstrates that Remdesivir Is a Highly Selective Antiviral Agent (2020 · Antimicrobial Agents and Chemotherapy · 被引 57)
• Intracellular Na+ overload causes oxidation of CaMKII and leads to Ca2+ mishandling in isolated ventricular myocytes (2014 · Journal of Molecular and Cellular Cardiology · 被引 57)
• Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection (2021 · JHEP Reports · 被引 52)
• Spatiotemporal Analysis of Hepatitis B Virus X Protein in Primary Human Hepatocytes (2019 · Journal of Virology · 被引 48)